Related Experiment Video
Updated: Jan 2, 2026

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Published on: June 2, 2022
The Gut Microbiome as a Therapeutic Target for Cognitive Impairment
Yi Sun1,2, Liliana C Baptista1,2, Lisa M Roberts1,2
1Department of Medicine, Division of Gerontology, Geriatrics and Palliative Care, School of Medicine.
Abstract:
Declining cognitive functions in older individuals have enormous emotional, clinical, and public health consequences. Thus, therapeutics for preserving function and keeping older adults living independently are imperative. Aging is associated dysbiosis, defined as a loss of number and diversity in gut microbiota, which has been linked with various aspects of cognitive functions. Therefore, the gut microbiome has the potential to be an important therapeutic target for symptoms of cognitive impairment. In this review, we summarize the current literature regarding the potential for gut-targeted therapeutic strategies for prevention/treatment of the symptoms of cognitive impairment. Specifically, we discuss four primary therapeutic strategies: wild-type and genetically modified probiotics, fecal microbiota transplantation, physical exercise, and high-fiber diets and specifically link these therapies to reducing inflammation. These strategies may hold promise as treatment paradigm symptoms related to cognitive impairment.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Alzheimer's Disease: Treatment
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Physiology of Enteric Nervous System and Gut Health
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

